SMPDL3B and benign prostatic hyperplasia: Therefore, SMPDL3B expression and its influence on clinical outcome was analyzed by real-time quantitative polymerase chain reaction (qRT-PCR) in two cohorts of patients with benign prostate hyperplasia (BPH), localized and locally advanced PCa.